Fertility Issues in Patients with Myoma

자궁근종과 생식력

  • Kim, So-Ra (Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Chae, Hee-Dong (Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center)
  • 김소라 (울산대학교 의과대학 서울아산병원 산부인과학교실) ;
  • 채희동 (울산대학교 의과대학 서울아산병원 산부인과학교실)
  • Received : 2010.08.09
  • Accepted : 2010.09.08
  • Published : 2010.09.30

Abstract

Uterine myomas are heterogeneous tumors in composition, size, location, and number; variation in any of these factors could possibly alter the effect on a woman's fertility status. The effect of myomas on fertility has been the subject of many studies. However, a definitive answer is still missing. The location and size of the myomas are the two parameters that influence the success of a future pregnancy. Subserosal myomas seem to have little effect on reproductive outcome. Myomas that compress the uterine cavity with an intramural portion and submucosal myomas significantly reduce pregnancy rates, and should be removed before assisted reproductive techniques are performed. Patients with intramural myomas also may have a poorer reproductive outcome, but the lacks of quality evaluations make this conclusion tenuous at best. Removal of myomas with an intra-cavitary component seems to be of benefit. However there are as yet no data to support myomectomy in the treatment of intramural myomas to improve fertility outcomes. Treatment modality for myomas located at intramural sites should be determined according to clinical status of the patient and doctor's experience.

자궁근종은 환자마다 다양한 조성, 크기, 위치, 개수를 가지는 양성 종양으로 여러 가지 방법으로 생식력에 영향을 준다. 자궁근종이 생식률에 미치는 영향에 대한 연구는 많이 시행되어 왔지만 여전히 명확한 결론을 내리기는 어렵다. 자궁근종의 위치와 크기는 향후 임신에 영향을 미치는 가장 중요한 인자이다. 장막하근종은 임신에 거의 영향을 주지 않으나 자궁내강의 모양을 변형시키는 점막하근종과 근층내근종은 임신율을 감소시키며 자연 유산율을 증가시킨다. 그러므로 보조생식술을 시행하기 전에는 먼저 제거하는 치료가 충분히 상의되어야 한다. 자궁내강을 변형시키지 않은 근층내근종이 있는 환자도 임신율의 저하를 보였지만, 확실한 연구가 없기 때문에 결론을 내리기가 쉽지 않다. 근층내근종의 치료로 근종절제술이 생식력을 향상시킨다는 증거는 아직 불충분하므로 환자의 상태와 의사의 경험에 따라 치료 방법을 결정하여야 한다.

Keywords

References

  1. Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007; 87: 725-36. https://doi.org/10.1016/j.fertnstert.2007.01.093
  2. Verkauf BS. Myomectomy for fertility enhancement and preservation. Fertil Steril 1992; 58: 1-15.
  3. Marshall LM, Spiegelman D, Goldman MB, Manson JE, Colditz GA, Barbieri RL, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998; 70: 432-9. https://doi.org/10.1016/S0015-0282(98)00208-8
  4. Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P. Reproductive factors and risk of uterine fibroids. Epidemiology 1996; 7: 440-2. https://doi.org/10.1097/00001648-199607000-00018
  5. Ramzy AM, Sattar M, Amin Y, Mansour RT, Serour GI, Aboulghar MA. Uterine myomata and outcome of assisted reproduction. Hum Reprod 1998; 13: 198-202. https://doi.org/10.1093/humrep/13.1.198
  6. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36: 433-45.
  7. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod 2002; 17: 1424-30. https://doi.org/10.1093/humrep/17.6.1424
  8. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991; 77: 923-6.
  9. Lumsden MA, West CP, Hawkins RA, Bramley TA, Rumgay L, Baird DT. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630). J Endocrinol 1989; 121: 389-96. https://doi.org/10.1677/joe.0.1210389
  10. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009; 91: 1215-1223. https://doi.org/10.1016/j.fertnstert.2008.01.051
  11. Kolankaya A, Arici A. Myomas and assisted reproductive technologies: when and how to act? Obstet Gynecol Clin North Am 2006; 33: 145-52. https://doi.org/10.1016/j.ogc.2005.12.008
  12. Stewart EA, Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol 1998; 92: 624-7. https://doi.org/10.1016/S0029-7844(98)00243-9
  13. Miura S, Khan KN, Kitajima M, Hiraki K, Moriyama S, Masuzaki H, et al. Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. Hum Reprod 2006; 21: 2545-54. https://doi.org/10.1093/humrep/del205
  14. Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update 1996; 2: 295-306. https://doi.org/10.1093/humupd/2.4.295
  15. Ng EH, Ho PC. Doppler ultrasound examination of uterine arteries on the day of oocyte retrieval in patients with uterine fibroids undergoing IVF. Hum Reprod 2002; 17: 765-70. https://doi.org/10.1093/humrep/17.3.765
  16. Sladkevicius P, Valentin L, Marsal K. Transvaginal Doppler examination of uteri with myomas. J Clin Ultrasound 1996; 24: 135-40. https://doi.org/10.1002/(SICI)1097-0096(199603)24:3<135::AID-JCU5>3.0.CO;2-I
  17. Surrey ES, Minjarez DA, Stevens JM, Schoolcraft WB. Effect of myomectomy on the outcome of assisted reproductive technologies. Fertil Steril 2005; 83: 1473-9. https://doi.org/10.1016/j.fertnstert.2004.11.045
  18. Check JH, Choe JK, Lee G, Dietterich C. The effect on IVF outcome of small intramural fibroids not compressing the uterine cavity as determined by a prospective matched control study. Hum Reprod 2002; 17: 1244-8. https://doi.org/10.1093/humrep/17.5.1244
  19. Hart R, Khalaf Y, Yeong CT, Seed P, Taylor A, Braude P. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod 2001; 16: 2411-7. https://doi.org/10.1093/humrep/16.11.2411
  20. Stovall DW, Parrish SB, Van Voorhis BJ, Hahn SJ, Sparks AE, Syrop CH. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod 1998; 13: 192-7. https://doi.org/10.1093/humrep/13.1.192
  21. Surrey ES, Lietz AK, Schoolcraft WB. Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril 2001; 75: 405-10. https://doi.org/10.1016/S0015-0282(00)01714-3
  22. Eldar-Geva T, Meagher S, Healy DL, MacLachlan V, Breheny S, Wood C. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril 1998; 70: 687-91. https://doi.org/10.1016/S0015-0282(98)00265-9
  23. Oliveira FG, Abdelmassih VG, Diamond MP, Dozortsev D, Melo NR, Abdelmassih R. Impact of subserosal and intramural uterine fibroids that do not distort the endometrial cavity on the outcome of in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril 2004; 81: 582-7. https://doi.org/10.1016/j.fertnstert.2003.08.034
  24. Baba K, Ishihara O, Hayashi N, Saitoh M, Taya J, Kinoshita K. Where does the embryo implant after embryo transfer in humans? Fertil Steril 2000; 73: 123-5. https://doi.org/10.1016/S0015-0282(99)00454-9
  25. Dubuisson JB, Fauconnier A, Chapron C, Kreiker G, Norgaard C. Second look after laparoscopic myomectomy. Hum Reprod 1998; 13: 2102-6. https://doi.org/10.1093/humrep/13.8.2102
  26. Fauconnier A, Dubuisson JB, Ancel PY, Chapron C. Prognostic factors of reproductive outcome after myomectomy in infertile patients. Hum Reprod 2000; 15: 1751-7. https://doi.org/10.1093/humrep/15.8.1751
  27. Rosati P, Bellati U, Exacoustos C, Angelozzi P, Mancuso S. Uterine myoma in pregnancy: ultrasound study. Int J Gynaecol Obstet 1989; 28: 109-17. https://doi.org/10.1016/0020-7292(89)90469-4
  28. Donnez J, Mathieu PE, Bassil S, Smets M, Nisolle M, Berliere M. Laparoscopic myomectomy today. Fibroids: management and treatment: the state of the art. Hum Reprod 1996; 11: 1837-40. https://doi.org/10.1093/oxfordjournals.humrep.a019502
  29. Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 1999; 93: 743-8. https://doi.org/10.1016/S0029-7844(98)00558-4
  30. Vercellini P, Zaina B, Yaylayan L, Pisacreta A, De Giorgi O, Crosignani PG. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol 1999; 94: 341-7. https://doi.org/10.1016/S0029-7844(99)00346-4
  31. Varasteh NN, Neuwirth RS, Levin B, Keltz MD. Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 1999; 94: 168-71. https://doi.org/10.1016/S0029-7844(99)00278-1
  32. Li TC, Mortimer R, Cooke ID. Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Hum Reprod 1999; 14: 1735-40. https://doi.org/10.1093/humrep/14.7.1735
  33. Marchionni M, Fambrini M, Zambelli V, Scarselli G, Susini T. Reproductive performance before and after abdominal myomectomy: a retrospective analysis. Fertil Steril 2004; 82: 154-9. https://doi.org/10.1016/j.fertnstert.2003.11.042
  34. Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 2000; 15: 2663-8. https://doi.org/10.1093/humrep/15.12.2663
  35. Ribeiro SC, Reich H, Rosenberg J, Guglielminetti E, Vidali A. Laparoscopic myomectomy and pregnancy outcome in infertile patients. Fertil Steril 1999; 71: 571-4. https://doi.org/10.1016/S0015-0282(98)00483-X
  36. Phillips DR, Milim SJ, Nathanson HG, Haselkorn JS. Experience with laparoscopic leiomyoma coagulation and concomitant operative hysteroscopy. J Am Assoc Gynecol Laparosc 1997; 4: 425-33. https://doi.org/10.1016/S1074-3804(05)80034-9
  37. Arcangeli S, Pasquarette MM. Gravid uterine rupture after myolysis. Obstet Gynecol 1997; 89: 857. https://doi.org/10.1016/S0029-7844(97)81430-5
  38. Vilos GA, Daly LJ, Tse BM. Pregnancy outcome after laparoscopic electromyolysis. J Am Assoc Gynecol Laparosc 1998; 5: 289-92. https://doi.org/10.1016/S1074-3804(98)80034-0
  39. Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 2002; 109: 1262-72. https://doi.org/10.1046/j.1471-0528.2002.01449.x
  40. McLucas B, Goodwin S, Adler L, Rappaport A, Reed R, Perrella R. Pregnancy following uterine fibroid embolization. Int J Gynaecol Obstet 2001; 74: 1-7. https://doi.org/10.1016/S0020-7292(01)00405-2
  41. Pron G, Bennett J, Common A, Wall J, Asch M, Sniderman K. The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003; 79: 120-7. https://doi.org/10.1016/S0015-0282(02)04538-7
  42. Goldberg J, Pereira L, Berghella V, Diamond J, Darai E, Seinera P, et al. Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 2004; 191: 18-21. https://doi.org/10.1016/j.ajog.2004.01.046
  43. Gavrilova-Jordan LP, Rose CH, Traynor KD, Brost BC, Gostout BS. Successful term pregnancy following MR-guided focused ultrasound treatment of uterine leiomyoma. J Perinatol 2007; 27: 59-61. https://doi.org/10.1038/sj.jp.7211624
  44. Bulletti C, D DEZ, Levi Setti P, Cicinelli E, Polli V, Stefanetti M. Myomas, pregnancy outcome, and in vitro fertilization. Ann N Y Acad Sci 2004; 1034: 84-92. https://doi.org/10.1196/annals.1335.010
  45. Harmanli O. Important features of study design. Fertil Steril 2005; 84: 1058-9.
  46. Pritts EA, Parker WH. Predictive value of myomectomy. Fertil Steril 2006; 86: 769-70. https://doi.org/10.1016/j.fertnstert.2006.07.1460